Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

BlueLinx Completes $40 Mln Rights Offering

BlueLinx Holdings Inc. (BXC: Quote) said Friday that it has completed its previously announced $40 million rights offering.

The company said previously that it would use the net proceeds of the rights offering of about $38.7 million to reduce the outstanding balance of its U.S. revolving credit facility.

Following the issuance of the newly subscribed shares, which is expected to occur on or about April 1, BlueLinx will have about 86.6 million total shares outstanding.

After giving effect to the offering, Cerberus ABP Investor LLC beneficially owns about 54.4% of BlueLinx' common stock.

Concurrent with the completion of the rights offering, BlueLinx's previously announced amendment and extension to its $400 million U.S. revolving credit facility became effective. As a result of the amendment and extension, the company's existing $400 million credit facility was increased by $22.5 million to $422.5 million and the maturity date was extended to April 15, 2016.

Click here to receive FREE breaking news email alerts for BlueLinx Holdings Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
This apparel maker has doubled its earnings per share in just two years and increased its annual earnings forecast from time to time, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.